INTERNATIONAL PATENT: GENENTECH, INC., F. HOFFMANN-LA ROCHE AG, HOFFMANN-LA ROCHE INC. FILES APPLICATION FOR "COMBINATIONS COMPRISING A KRAS G12C INHIBITOR, PEMBROLIZUMAB AND A STEROID"

GENEVA, Jan. 27 -- GENENTECH, INC. (1 DNA WaySouth San Francisco, California 94080-4990), F. HOFFMANN-LA ROCHE AG (Grenzacherstrasse 1244070 Basel), HOFFMANN-LA ROCHE INC. (150 Clove Road, Overlook at Great NotchSuite 8Little Falls, New Jersey 07424) filed a patent application (PCT/US2025/038034) for "COMBINATIONS COMPRISING A KRAS G12C INHIBITOR, PEMBROLIZUMAB AND A STEROID" on Jul 17, 2025. With publication no. WO/2026/019991, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LIN, Ting-Kun Mark (c/o Genentech, Inc.1 DNA W...